AUTONOMIX MEDICAL INC
AMIXNASDAQπ #5191 by market capUS Equity
$1.03βΌ $0.08 (β6.79%)
Market closed Β· at closeTrack AMIX
Get earnings, price moves & breaking news on Telegram
24hβΌ 6.8%
7dβΌ 24.3%
14dβΌ 36.8%
30dβΌ 57.4%
ytdβΌ 91.1%
1yβΌ 95.2%
π¦Market Cap
$2M
Small Cap
πRevenue Growth (YoY)
β
πGross Margin
β
π΅FCF Margin
β
βοΈP/S Ratio
β
Otter Score
β
Insufficient data
Trading Snapshot
- Day Range
- $1.03 β $1.10
- 52-Week Range
- $0.88 β $24.68
- Volume (shares)
- 1,443
- Avg Volume (shares)
- β
- Shares Outstanding
- 2.0M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- β
- Last Q Revenue
- β
- P/E Ratio
- β
- P/S Ratio
- β
- EPS (TTM)
- $-46.50
- Dividend Yield
- β
- Dilution (1yr)
- +192.5%
AUTONOMIX MEDICAL INC
AMIXFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnβt profitable yet.
β$17Mβ² +47.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
β$12Mβ² +48.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerβs slice.
1.2Mβ² +192.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$8MβΌ β$2M YoY
About AUTONOMIX MEDICAL INC
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The companyβs technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
π¦¦
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
π§Dilutionβ
β
β
β
β
Overall Score
Insufficient data
β/100
Analyst Ratings
βConsensus
Buy
8 analysts
Strong Buy3
Buy4
Hold1
Sell0
Strong Sell0
Ratings as of Nov 2026
Latest News & Updates
News unavailable.